In the case of a 58-year-old male with a newly diagnosed IDH-mutant grade 2 astrocytoma and subtotal resection, the majority of clinicians, including 96% of medical oncologists, 100% of radiation oncologists and 67% of surgeons, recommended additional treatment [Figure 7]. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).